Antibacterial agent 102
Antibacterial agent 102 (compound 32) possesses potent in vitro and in vivo antibacterial activity, with MICs Staphylococcus aureus (S. aureus) . Antibacterial agent 102 also moderately inhibits CYP3A4 with an IC50 value of 6.148 μM. Antibacterial agent 102 can reduce Methicillin-resistant Staphylococcus aureus (MRSA) load in thigh infected mice[1].
Product Specifications
CAS Number
2413293-65-7
UNSPSC
12352005
Target
Bacterial; Cytochrome P450
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/antibacterial-agent-102.html
Solubility
10 mM in DMSO
Smiles
O=C(O[C@H]1[C@]2(C)[C@@H](CC[C@]3([C@H]([C@@H]([C@](C=C)(C1)C)O)C)[C@]2(C(CC3)=O)[H])C)CSC4=C(NC(CN5C=C(CN(C)C)N=N5)=O)C=CC=C4
Molecular Formula
C35H49N5O5S
Molecular Weight
651.86
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CYP3
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
C22orf36 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Annexin V (ANXA5) (NM_001154) Human Over-expression Lysate
Synaptojanin (SYNJ1) (NM_001160306) Human Tagged Lenti ORF Clone